Cargando…
Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
INTRODUCTION: Cancer testis (CT) antigens are attractive targets for cancer immunotherapy because of their expression restriction and immunogenicity. The acrosin binding protein (ACRBP) is a member of CT antigens. This study aimed to evaluate ACRBP expression and immunogenicity in ovarian cancer (OC...
Autores principales: | Lin, Lina, Nong, Weixia, Luo, Bin, Ge, Yingying, Zeng, Xia, Li, Feng, Fan, Rong, Zhang, Qingmei, Xie, Xiaoxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589352/ https://www.ncbi.nlm.nih.gov/pubmed/34528758 http://dx.doi.org/10.1002/iid3.534 |
Ejemplares similares
-
Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma
por: Li, Xisheng, et al.
Publicado: (2017) -
Behavior of ACRBP-deficient mouse sperm in the female reproductive tract
por: NAGASHIMA, Kiyoshi, et al.
Publicado: (2018) -
Immunohistochemistry Study of OY-TES-1 Location in Fetal and Adult Human Tissues
por: Fu, Jun, et al.
Publicado: (2022) -
Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023) -
Differential Antigen Expression Profile Predicts Immunoreactive Subset of Advanced Ovarian Cancers
por: Eng, Kevin H., et al.
Publicado: (2014)